Cargando…
Impact of Serotonin Transporter Gene Polymorphism on Gut Motility in Patients With Type 2 Diabetes Mellitus
BACKGROUND/AIMS: The pathogenesis of gastrointestinal (GI) symptoms in patients with type 2 diabetes mellitus (T2DM) is yet to be delineated clearly. Serotonin, a monoamine neurotransmitter, resides primarily in the gut and plays a vital role in GI system. However, no study has been documented the r...
Autores principales: | Malik, Aastha, Saha, Sarama, Morya, Rajesh K, Bhadada, Sanjay K, Rana, Satya V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Neurogastroenterology and Motility
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026373/ https://www.ncbi.nlm.nih.gov/pubmed/33526751 http://dx.doi.org/10.5056/jnm20211 |
Ejemplares similares
-
Association between serotonin transporter gene polymorphism and recurrent aphthous stomatitis
por: Manchanda, Aastha, et al.
Publicado: (2016) -
COVID-19 and diabetes mellitus: An unholy interaction of two pandemics
por: Pal, Rimesh, et al.
Publicado: (2020) -
Medical Nutrition Therapy in Type 1 Diabetes Mellitus
por: Rani, K. Sandhya, et al.
Publicado: (2017) -
Serotonin transporter polymorphisms and panic disorder
por: Schumacher, Johannes, et al.
Publicado: (2010) -
Psychological Aspects Related to Diabetes Mellitus
por: Gupta, Nitin, et al.
Publicado: (2016)